Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Zai Lab completes $160mm US IPO

Executive Summary

Chinese drug developer Zai Labs Ltd. completed its initial public offering in the US, netting $160mm through the sale of 9.58mm American Depositary Shares (including the overallotment; representing 9.58mm common) at $18 per ADS. Earlier this month, the company stated that it hoped to sell 5.88mm ADSs at a range of $16-18.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies